Physician profile
Jonathan Opraseuth
NPI 1245490598
$2,592.18
in general payments reported to CMS, 2019-2025
8 companies · $725 in 2025
The $725 reported for 2025 was more than what 82% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2022: $467 · 2023: $523 · 2024: $445 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $768.93 | 2022-2025 | Spinejack, Omnicurve, Clottriever Bold Catheter |
| Inari Medical, INC. | $609.92 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic USA, INC. | $431.75 | 2019 | |
| Relievant Medsystems, INC. | $322.13 | 2022-2023 | Intracept |
| Medtronic, INC. | $165.72 | 2024-2025 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Boston Scientific Corporation | $135.52 | 2023-2024 | Spyglass, Embold Fibered |
| Penumbra, INC. | $134.11 | 2022 | |
| Recor Medical INC | $24.10 | 2025 | Paradise Ultrasound Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Opraseuth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.